Feedback plc Stock
Your prediction
Pros and Cons of Feedback plc in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Feedback plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Feedback plc | 1.480% | -0.725% | 33.010% | -55.519% | -31.500% | -93.150% | -92.389% |
| Allerthal-werke-Ag | -0.770% | -0.769% | 3.200% | 13.158% | 19.444% | 9.322% | -9.790% |
| Cfc Industriebeteiligungen | 3.810% | -8.403% | 14.979% | -35.882% | 39.744% | -60.219% | -33.939% |
| Gatekeeper Systems Inc | 5.660% | -4.990% | 18.270% | 20.621% | -17.712% | 297.951% | 126.077% |
News
aTyr Pharma Revamps Efzofitimod Path With New Phase III Sarcoidosis Trial
aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after receiving feedback from the U.S. Food and Drug Administration at a recent Type
